Ingrid A Boere (Ingrid Boere)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Metastatic Colorectal Cancer

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

BJOG : an international journal of obstetrics and gynaecology

This page only lists publications with an associated author ORCID identifier.

Publications

M I E van Poelgeest, Kim E Kortekaas, H Lena C van Doorn, Maaike Oonk, Hans W Nijman, Ingrid A Boere, Anneke L Eerkens, Anna K L Reyners, Patricia C Ewing-Graham, Joost Bart, Tjalling Bosse, Marij J P Welters, Judith R Kroep, Sjoerd H van der Burg
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Tugce Senturk Kirmizitas, Caroline van den Berg, Ruben G Boers, Jean Helmijr, Stavros Makrodimitris, Hamit Harun Dag, Marijn Kerkhofs, Corine Beaufort, Jaco Kraan, Wilfred F J Van IJcken, Joost Gribnau, Pakriti Garkhail, Gatske Nieuwenhuyzen-de Boer, Eva-Maria Roes, Heleen van Beekhuizen, Tuba Gunel, Saskia M Wilting, John W M Martens, Maurice Jansen, Ingrid A Boere
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients. Genes 15 (6) (2024)
Jonathan Servayge, Ester Paulien Olthof, Constantijne H Mom, Maaike A van der Aa, Hans H B Wenzel, Jacobus van der Velden, Remi A Nout, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy. Cancers 16 (3) (2024)
Jonathan Servayge, Ester Paulien Olthof, Constantijne H Mom, Maaike A van der Aa, Hans H B Wenzel, Jacobus van der Velden, Remi A Nout, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy. Cancers 16 (3) (2024)
M I E van Poelgeest, Kim E Kortekaas, H Lena C van Doorn, Maaike Oonk, Hans W Nijman, Ingrid A Boere, Anneke L Eerkens, Ann Reyners, Patricia C Ewing-Graham, Joost Bart, Tjalling Bosse, Marij J P Welters, Judith R Kroep, Sjoerd H van der Burg
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Mayuri Charnalia, Supriya Chopra, Jaahid Mulani, Palak Popat, Sushmita Rath, Maarten Thomeer, Prachi Mittal, Ankita Gupta, Ingrid A Boere, Sudeep Gupta, Remi A Nout
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (6) (2024)
Tugce Senturk Kirmizitas, Caroline van den Berg, Ruben G Boers, Jean Helmijr, Stavros Makrodimitris, Hamit Harun Dag, Marijn Kerkhofs, Corine Beaufort, Jaco Kraan, Wilfred F J Van IJcken, Joost Gribnau, Pakriti Garkhail, Gatske Nieuwenhuyzen-de Boer, Eva-Maria Roes, Heleen van Beekhuizen, Tuba Gunel, Saskia M Wilting, John W M Martens, Maurice Jansen, Ingrid A Boere
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients. Genes 15 (6) (2024)
Mayuri Charnalia, Supriya Chopra, Jaahid Mulani, Palak Popat, Sushmita Rath, Maarten Thomeer, Prachi Mittal, Ankita Gupta, Ingrid A Boere, Sudeep Gupta, Remi A Nout
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Joosje H Heimovaara, Evangeline A Huis In 't Veld, Christianne A R Lok, Alvaro Cabrera Garcia, Michael J Halaska, Ingrid A Boere, Mina Mhallem Gziri, Robert Fruscio, Rebecca C Painter, Elyce H Cardonick, Marry M M van den Heuvel-Eibrink, B Masturzo, Kristel Van Calsteren, Lia van Zuylen, Frédéric Amant, null null
Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and Pregnancy. BJOG : an international journal of obstetrics and gynaecology (2024)
Tugce Senturk Kirmizitas, Caroline van den Berg, Ruben G Boers, Jean Helmijr, Stavros Makrodimitris, Hamit Harun Dag, Marijn Kerkhofs, Corine Beaufort, Jaco Kraan, Wilfred F J Van IJcken, Joost Gribnau, Pakriti Garkhail, Gatske Nieuwenhuyzen-de Boer, Eva-Maria Roes, Heleen van Beekhuizen, Tuba Gunel, Saskia M Wilting, John W M Martens, Maurice Jansen, Ingrid A Boere
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients. Genes 15 (6) (2024)
Eleni Karamouza, Rosalind M Glasspool, Caroline A Kelly, Liz-Anne Lewsley, Karen Carty, Gunnar B Kristensen, Josee-Lyne Ethier, Tatsuo Kagimura, Nozomu Yanaihara, Sabrina Chiara Cecere, Benoit You, Ingrid A Boere, Eric Pujade-Lauraine, Isabelle L Ray-Coquard, Cécile Proust-Lima, Xavier Paoletti
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data. Cancers 15 (6) (2023)
Ingrid A Boere, Ignace Vergote, Rob Hanssen, Mathilde Jalving, Christine Gennigens, Petronella Ottevanger, Yes J van de Wouw, Cristianne J F Rijcken, Ron H J Mathijssen, Jonathan A Ledermann
CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ignace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill, Anneke M Westermann, Domenica Lorusso, Sharad Ghamande, Dearbhaile C Collins, Susana Banerjee, Cara A Mathews, Christine Gennigens, David Cibula, Krishnansu S Tewari, Kristine Madsen, Fatih Köse, Amanda L Jackson, Ingrid A Boere, Giovanni Scambia, Leslie M Randall, Azmat Sadozye, Jean-François Baurain, Eelke H Gort, Michal Zikán, Hannelore G Denys, Petronella B Ottevanger, Frédéric Forget, Camilla Mondrup Andreassen, Lamar Eaton, Michael J Chisamore, Leonardo Viana Nicacio, Ibrahima Soumaoro, Bradley J Monk
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Eleni Karamouza, Rosalind M Glasspool, Caroline A Kelly, Liz-Anne Lewsley, Karen Carty, Gunnar B Kristensen, Josee-Lyne Ethier, Tatsuo Kagimura, Nozomu Yanaihara, Sabrina Chiara Cecere, Benoit You, Ingrid A Boere, Eric Pujade-Lauraine, Isabelle L Ray-Coquard, Cécile Proust-Lima, Xavier Paoletti
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data. Cancers 15 (6) (2023)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Chris J de Witte, Joachim Kutzera, Arne van Hoeck, Luan Nguyen, Ingrid A Boere, Mathilde Jalving, Petronella B Ottevanger, Christa van Schaik-van de Mheen, Marion A Stevense-den Boer, Wigard P Kloosterman, Ronald P Zweemer, Edwin Cuppen, Petronella O Witteveen
Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer. Cancers 14 (6) (2022)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Leni van Doorn, Mandy M van Rosmalen, Wendy M van der Deure, Esther Oomen-de Hoop, Robert Porrazzo, Sophie M Wijngaard, Ingrid A Boere, Paola Veenstra, Eman Ibrahim, Peter de Bruijn, Lena E Friberg, Stijn L W Koolen, Ron H J Mathijssen, Agnes Jager
Effect of Scalp Cooling on the Pharmacokinetics of Paclitaxel. Cancers 13 (15) (2021)
Claudia Berends, Charlotte Maggen, Christianne A R Lok, Mathilde van Gerwen, Ingrid A Boere, Vera E R A Wolters, Kristel Van Calsteren, Heidi Segers, Marry M van den Heuvel-Eibrink, Rebecca C Painter, Mina Mhallem Gziri, Frédéric Amant
Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy. Cancers 13 (6) (2021)
Nanda Horeweg, Prachi Mittal, Patrycja L Gradowska, Ingrid A Boere, Supriya Chopra, Remi A Nout
Adjuvant Systemic Therapy after Chemoradiation and Brachytherapy for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis. Cancers 13 (8) (2021)
Anouk Corbeau, Remi A Nout, Jan Willem M Mens, Nanda Horeweg, Jérémy Godart, Ellen M Kerkhof, Sander C Kuipers, Mariette I E van Poelgeest, Judith R Kroep, Ingrid A Boere, H Lena C van Doorn, Mischa S Hoogeman, Uulke A van der Heide, Hein Putter, Marij J P Welters, Sjoerd H Van der Burg, Carien L Creutzberg, Stephanie M de Boer
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System. Cancers 13 (20) (2021)